Full Text View
Tabular View
Study Results
Related Studies
Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC
This study has been terminated.
( Sponsors withdrew funding; preliminary efficacy data was not encouraging. )
Study NCT00801801   Information provided by University of Alabama at Birmingham

First Received on December 2, 2008.   Last Updated on June 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial